Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019.
Saved in:
| Title: | Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019. |
|---|---|
| Authors: | Garrison LP Jr; VeriTech Corporation, Mercer Island, WA, USA; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA. Electronic address: lgarrisn@uw.edu., Jiao B; VeriTech Corporation, Mercer Island, WA, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Elsisi Z; VeriTech Corporation, Mercer Island, WA, USA; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA., Yehoshua A; Gilead Sciences, Inc Foster City, CA, USA., Koruth R; Gilead Sciences, Inc Foster City, CA, USA., Kreter B; Gilead Sciences, Inc Foster City, CA, USA., Grueger J; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA; Boston Consulting Group Zurich, Healthcare Practice Area, Zurich, Switzerland. |
| Source: | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug; Vol. 27 (8), pp. 1021-1029. Date of Electronic Publication: 2024 Apr 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1524-4733 |
|---|---|
| DOI: | 10.1016/j.jval.2024.04.011 |
